Commercialization of microwave thermokeratoplasty

Information

  • Research Project
  • 6694909
  • ApplicationId
    6694909
  • Core Project Number
    R44EY015085
  • Full Project Number
    1R44EY015085-01
  • Serial Number
    15085
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/2003 - 21 years ago
  • Project End Date
    8/31/2004 - 20 years ago
  • Program Officer Name
    HELMSEN, RALPH J
  • Budget Start Date
    9/1/2003 - 21 years ago
  • Budget End Date
    8/31/2004 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/21/2003 - 21 years ago
Organizations

Commercialization of microwave thermokeratoplasty

DESCRIPTION (provided by applicant): Microwave Thermokeratoplasty (MTK) shrinks the stromal (middle) layer of the cornea in a ring pattern around the pupil in response to elevation of temperature by absorption of microwave energy; the central cornea flattens as a result, thus correcting for myopia. About 50% of the U.S. population requires correction for myopia. This novel method has advantages over the most common surgical treatment for myopia, laser assisted in-situ keratomileusis (LASIK). Specifically, MTK: [unreadable] Involves no surgical intervention in the central cornea. [unreadable] Requires no period of healing. [unreadable] Does not use expensive equipment. [unreadable] Involves only a single, 2-second treatment. [unreadable] Spares the corneal epithelium through its cooling system. [unreadable] Avoids the dry eye complication characteristic of LASIK. We will improve the existing MTK system by incorporating a feedback system to achieve precise results and an optical centering system to assist placement on the cornea. We will evaluate the redesigned system in ex vivo and in vivo corneas and quantify the improvement in predictability and repeatability of refractive effect. In Phase I, we will perform an in vivo acute study in five subjects. In Phase II, we will perform an in vivo chronic study with a 3- month follow-up period. This work will support our application to the FDA for an Investigational Device Exemption.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    R44
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    117175
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    867
  • Ed Inst. Type
  • Funding ICs
    NEI:117175\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    AVEDRO, INC.
  • Organization Department
  • Organization DUNS
    007274362
  • Organization City
    WALTHAM
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    024517552
  • Organization District
    UNITED STATES